Results 91 to 100 of about 1,335,871 (234)
Chinese Society of Clinical Oncology, Expert Committee on Non-small Cell Lung Cancer
doaj +1 more source
Charalampos Dimitropoulos1, Georgios Hillas2, Sofia Nikolakopoulou2, Ioanna Kostara2, Konstantinos Sagris2, Fotis Vlastos2, Manos Alchanatis319th Respiratory Medicine Department; 2Department of Respiratory and Critical Care Medicine, Research Unit ...
Dimitropoulos C +6 more
doaj
Marybeth Sechler,1,2 Amber D Cizmic,3 Sreedevi Avasarala,1 Michelle Van Scoyk,1 Christine Brzezinski,1 Nicole Kelley,1 Rama Kamesh Bikkavilli,1 Robert A Winn1–3 1Division of Pulmonary Sciences and Critical Care, 2Program in Cancer Biology ...
Sechler M +7 more
doaj
New antiangiogenics in non-small cell lung cancer treatment: Vargatef™ (BIBF 1120) and beyond
Bruno Gori1, Serena Ricciardi1, Alberto Fulvi1, Salvatore Intagliata2, Ester Del Signore1, Filippo de Marinis11Oncological-Pulmonary Unit 1st, San Camillo Hospital, Rome, Italy; 2Department of Medical Oncology, University Campus Bio-Medico, Rome ...
Gori B +5 more
doaj
2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer [PDF]
To complement the existing treatment guidelines, ESMO organises consensus conferences to focus on specific issues. The 2nd ESMO Consensus Conference on Lung Cancer included 35 experts who met to address several questions on non-small-cell lung cancer ...
Adjei, Alex +79 more
core
Iterative surgical resections in non-small cell lung cancer
Ahmet Ucvet +5 more
doaj +1 more source
A tüdőrák molekuláris patológiai vizsgálatának feltételei [PDF]
From the aspect of the contemporary pathologic diagnostics of lung cancer the tissue obtained is a key issue since small biopsies and cytology still play a major role.
Tímár József
core
Alterations of Eph receptor tyrosine kinases are frequent events in human cancers. Genetic variations of EPHB6 have been described but the functional outcome of these alterations is unknown.
Bulk, E.M. (Etmar) +9 more
core +1 more source
Gene expression-based classification of non-small cell lung carcinomas and survival prediction [PDF]
Background: Current clinical therapy of non-small cell lung cancer depends on histo-pathological classification. This approach poorly predicts clinical outcome for individual patients.
Aerts, J.G.J.V. (Joachim) +11 more
core
Thoracic Surgery Committee on Adjuvant Therapy of Non-small Cell Lung Cancer
doaj +1 more source

